Takaya, H.; Namisaki, T.; Enomoto, M.; Kubo, T.; Tsuji, Y.; Fujinaga, Y.; Nishimura, N.; Kaji, K.; Kawaratani, H.; Moriya, K.;
et al. The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure. Biology 2023, 12, 164.
https://doi.org/10.3390/biology12020164
AMA Style
Takaya H, Namisaki T, Enomoto M, Kubo T, Tsuji Y, Fujinaga Y, Nishimura N, Kaji K, Kawaratani H, Moriya K,
et al. The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure. Biology. 2023; 12(2):164.
https://doi.org/10.3390/biology12020164
Chicago/Turabian Style
Takaya, Hiroaki, Tadashi Namisaki, Masahide Enomoto, Takahiro Kubo, Yuki Tsuji, Yukihisa Fujinaga, Norihisa Nishimura, Kosuke Kaji, Hideto Kawaratani, Kei Moriya,
and et al. 2023. "The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure" Biology 12, no. 2: 164.
https://doi.org/10.3390/biology12020164
APA Style
Takaya, H., Namisaki, T., Enomoto, M., Kubo, T., Tsuji, Y., Fujinaga, Y., Nishimura, N., Kaji, K., Kawaratani, H., Moriya, K., Akahane, T., Matsumoto, M., & Yoshiji, H.
(2023). The Ratio of von Willebrand Factor Antigen to ADAMTS13 Activity: Usefulness as a Prognostic Biomarker in Acute-on-Chronic Liver Failure. Biology, 12(2), 164.
https://doi.org/10.3390/biology12020164
